AR069223A1 - Combinacion antihelmintica - Google Patents
Combinacion antihelminticaInfo
- Publication number
- AR069223A1 AR069223A1 ARP080104874A ARP080104874A AR069223A1 AR 069223 A1 AR069223 A1 AR 069223A1 AR P080104874 A ARP080104874 A AR P080104874A AR P080104874 A ARP080104874 A AR P080104874A AR 069223 A1 AR069223 A1 AR 069223A1
- Authority
- AR
- Argentina
- Prior art keywords
- combination
- antihelmintic
- compositions
- controlling
- trichlorfon
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/30—Nitrogen atoms not forming part of a nitro radical
- C07D235/32—Benzimidazole-2-carbamic acids, unsubstituted or substituted; Esters thereof; Thio-analogues thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/10—Anthelmintics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP07120380 | 2007-11-09 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR069223A1 true AR069223A1 (es) | 2010-01-06 |
Family
ID=39059330
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP080104874A AR069223A1 (es) | 2007-11-09 | 2008-11-07 | Combinacion antihelmintica |
Country Status (7)
Country | Link |
---|---|
CN (1) | CN101848710A (pt) |
AR (1) | AR069223A1 (pt) |
AU (1) | AU2008324095A1 (pt) |
BR (1) | BRPI0820260A2 (pt) |
MX (1) | MX2010004852A (pt) |
WO (1) | WO2009060063A1 (pt) |
ZA (1) | ZA201002315B (pt) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR079409A1 (es) * | 2009-09-07 | 2012-01-25 | Mukhopadhyay Debashis | Preparaciones antihelminticas granuladas y sistemas de suninistros |
PL2793874T3 (pl) | 2011-12-20 | 2017-06-30 | Ectin Research Ab | Synergistyczna kombinacja do inhibicji guza |
CN102743403A (zh) * | 2012-06-26 | 2012-10-24 | 格特生物制药(天津)有限公司 | 一种家畜用驱虫片剂及其制备方法 |
CN102726443B (zh) * | 2012-07-12 | 2013-11-27 | 中国林业科学研究院亚热带林业研究所 | 依维菌素与敌百虫复配农药 |
RU2699799C1 (ru) * | 2019-01-10 | 2019-09-11 | Федеральное государственное бюджетное учреждение науки Сибирский федеральный научный центр агробиотехнологий Российской академии наук (СФНЦА РАН) | Противопаразитарная композиция и способ ее применения для лечения паразитозов жвачных животных |
CN113755610B (zh) * | 2021-10-08 | 2023-09-12 | 内蒙古自治区农牧业科学院 | 用于检测捻转血矛线虫对伊维菌素敏感性的基因及应用 |
CN114452314A (zh) * | 2022-01-12 | 2022-05-10 | 河南百草元兽药有限公司 | 一种阿苯达唑伊维菌素粉及其制备方法 |
CN114569561A (zh) * | 2022-03-28 | 2022-06-03 | 中牧实业股份有限公司黄冈动物药品厂 | 一种阿苯达唑伊维菌素粉及其制备方法与应用 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1069032C (zh) * | 1997-03-27 | 2001-08-01 | 中国农业大学 | 一种含阿维菌素/依维菌素的兽用抗寄生虫药 |
AU2003900505A0 (en) * | 2003-02-05 | 2003-02-20 | Jurox Pty Ltd | Anthelmintic composition |
-
2008
- 2008-11-07 AR ARP080104874A patent/AR069223A1/es unknown
- 2008-11-07 AU AU2008324095A patent/AU2008324095A1/en not_active Abandoned
- 2008-11-07 BR BRPI0820260-5A patent/BRPI0820260A2/pt not_active IP Right Cessation
- 2008-11-07 CN CN200880114965A patent/CN101848710A/zh active Pending
- 2008-11-07 MX MX2010004852A patent/MX2010004852A/es not_active Application Discontinuation
- 2008-11-07 WO PCT/EP2008/065126 patent/WO2009060063A1/en active Application Filing
-
2010
- 2010-03-31 ZA ZA2010/02315A patent/ZA201002315B/en unknown
Also Published As
Publication number | Publication date |
---|---|
AU2008324095A1 (en) | 2009-05-14 |
CN101848710A (zh) | 2010-09-29 |
BRPI0820260A2 (pt) | 2015-05-26 |
MX2010004852A (es) | 2010-06-02 |
WO2009060063A1 (en) | 2009-05-14 |
ZA201002315B (en) | 2010-11-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR069223A1 (es) | Combinacion antihelmintica | |
DOP2010000304A (es) | Composiciones y metodos de preparacion y uso de las mismas | |
PA8772101A1 (es) | Imidazol-triazolopirimidinas sustituidas | |
BR112015011036A2 (pt) | derivados de 2-amino-quinazolina substituídos heterocíclicos para o tratamento de infecções virais | |
CL2008000862A1 (es) | Compuestos derivados de triazolonas, inhibidores no nucleosidos de transcriptasa inversa; composicion farmaceutica que contiene a dichos compuestos; y uso del compuesto para tratar la infeccion del vih-1. | |
GT201400111A (es) | Triazolopiridinas sustituidas | |
CL2009000349A1 (es) | Compuestos derivados de 4,5-dihidro-oxazol-2-ilamina; procedimiento de preparacion; composicion farmaceutica; y su uso para el tratamiento de la enfermedad de alzheimer. | |
PE20150200A1 (es) | Formulacion de anticuerpos | |
CL2007002635A1 (es) | Compuestos derivados de quinazolinona e isoquinolinona, moduladores de la actividad del eje hpa; composicion farmaceutica que los comprende; y su uso en el tratamiento y/o prevencion relacionado con estres o depresion. | |
CL2011000195A1 (es) | Compuestos derivados de 5-alquinil-pirimidina, inhibidores de quinasas; composiciones farmaceuticas que comprenden a los compuestos; y uso de los compuestos en la preparacion de medicamentos para el tratamiento del cancer. | |
ECSP11010818A (es) | Métodos para administrar formulaciones antifúngicas tópicas para el tratamiento de infecciones fúngicas | |
AR064614A1 (es) | Producto combinado par controlar parasitos en animales | |
AR057946A1 (es) | Formulacion de zonisamida de liberacion sostenidda | |
CL2008002430A1 (es) | Compuestos derivados de bencenosulfonamida, inhibidores de catepsina c; composicion farmaceutica que los comprende; y su uso para el tratamiento de la epoc. | |
GT200800187A (es) | Compuestos de tetrahidropiridotienopirimidina y procedimientos de uso de los mismos | |
CL2011002675A1 (es) | Uso de compuestos derivados de nitrato o sulfato de 9-purin-9-il-3,4-dihidroxitetrahidrofuran-2-il-metilo para reducir la presion intraocular ; composicion farmaceutica oftalmica que comprende los compuestos; y formulacion oftalmica de uso topico que los comprende. | |
NI201000189A (es) | Formulación de medicamento sólido con liberación retardadas. | |
UY30214A1 (es) | Modificaciones de ( 5s) -5-(4-(5-cloro-piridin--2-iloxi)-piperidina-1-sulfonilmetil)-5-metil-imidazolidina-2,4-diona, procesos para su preparacion, composiciones que los contengan y aplicaciones. | |
CL2007001748A1 (es) | Compuesto derivado de 2-arilamino-4-aminopirimidinas, inhibidores de la proteina quinasa c-alfa; composiciones farmaceuticas que los contienen; y su uso para tratar o prevenir la diabetes, el cancer, enfermedades cardiovasculares y otras. | |
GT201300125A (es) | 1h-pirazol-5-olato sódico sustituido | |
CL2007002862A1 (es) | Uso del factor de crecimiento epidermico (egf) para tratar neuropatia sensitivo-motora, dolorosa y manifestaciones de neuritis isquemicas; composicion farmaceutica que comprende egf; y uso de la composicion antes dicha. | |
UY31128A1 (es) | Formulacion de nevirapina de liberacion prolongada | |
UY29417A1 (es) | Agentes endoparasiticidas | |
CL2009000904A1 (es) | Compuestos derivados de ciclohexil sulfonamidas que tienen actividad antagonista en el receptor npy y5, composicion farmaceutica y formulacion farmaceutica que los comprende. | |
PA8806501A1 (es) | Triazolotriazinas y triazolopirazinas y su uso |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |